Cobimetinib Plus Vemurafenib in Patients With Colorectal Cancer With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
Kelsey A KluteMichael RotheElizabeth Garrett-MayerPam K MangatReza NazemzadehKathleen J YostHerbert L DuvivierEugene R AhnTimothy L CannonOlatunji B AleseJohn C KraussRamya ThotaCarmen J CalfaCrystal S DenlingerRaegan O'LoneSusan HalabiGina N GranthamRichard L SchilskyPublished in: JCO precision oncology (2022)
mutations.
Keyphrases